| Literature DB >> 33402930 |
Meriem Rouag1, Salma Berrouague1, Nesrine Djaber1, Taha Khaldi1, Mahieddine Boumendjel1, Faiza Taibi1, Cherif Abdennour2, Amel Boumendjel1, Mahfoud Messarah1.
Abstract
BACKGROUND: Nitrate (NO3) is the most common chemical contaminant in the world's ground water aquifer. Oxidative stress has been proposed as a possible mechanism involved in NO3 toxicity on non-target organism.Entities:
Keywords: Sodium nitrate; Telfairia occidentalis; anti-oxidant status; hepatotoxicity; oxidative stress; protection; pumpkin seed oil; rat
Mesh:
Substances:
Year: 2020 PMID: 33402930 PMCID: PMC7750078 DOI: 10.4314/ahs.v20i1.48
Source DB: PubMed Journal: Afr Health Sci ISSN: 1680-6905 Impact factor: 0.927
Polyphenols, flavonoids, tannins contents and antioxidant activity of PSO (DPPH, CAT and ABTS).
| Parameters | Contents |
| Polyphenols (mg gallique acid equivalent / g of PSO) | 1.45±0.01 |
| Flavonoids (mg quercetin acid equivalents /g PSO) | 1.35±0.01 |
| Tannins (mg catechin equivalents /g PSO) | 0.98±0.01 |
| Percentage scavenging concentration (mg/ml) on DPPH radical | 187.56±5.78 |
| CAT (mg Vit C/g PSO) | 3.78± 0.22 |
| ABTS (mM Trolox E /g PSO) | 1.45± 0.01 |
Values are means ± SEM, triplicate for each parameter.
Body weight, absolute and relative liver weight, food intake, water consumption of control and treated rats with NaNO3, PSO or their combination (NaNO3/PSO) during 28 days.
| Parameters and treatments | Control | NaNO3 | PSO | NaNO3/PSO |
| Initial body weights (g) | 265.33±4.81 | 265.3±3.63 | 265.16±4.58 | 265±4.67 |
| Final body weights (g) | 300.57±5.22 | 274.14±3.04*** | 290.125±6.48 | 283.375±5.1 |
| Absolute liver weight (mg) | 7.04±0.19 | 8.01±0.16** | 7.15±0.16## | 7.13±0.22## |
| Relative liver weights | 2.36±0.09 | 2.95±0.09*** | 2.43±0.07## | 2.5±0.1## |
| Food intake(g/day/rat) | 19.77±0.05 | 19.61±0.04*** | 18.35±0.17 ***### | 17.6±0.14***## |
| water consumption (ml/day/rat) | 29.37±0.09 | 29.39±0.07 | 26.92±0.42***### | 27.63±0.37***### |
| Quantities of NaNO3 ingested | ----- | 77.90±0.21 | ----- | 73.22±0.96 |
Values are means ± SEM, n: number of animals in each group.
*p<0.05, **p<0.01, ***p<0.001: significantly different from control group.
#p<0.05, ##p<0.01, ###p<0.001: significantly different from NaNO3.
Hematological parameters in control and treated rats with NaNO3, PSO or their combination (NaNO3/PSO) during 28 days.
| Parameters and | Control | NaNO3 | PSO | NaNO3/PSO |
| RBC (106/µL) | 9.55±0.23 | 8.46±0.22** | 9.97±0.28## | 9.39±0.28# |
| WBC (103/µL) | 9.53±0.3 | 15.45±1.27*** | 8.51±0.34*## | 9.72±0.54## |
| PLT (103/µL) | 332.5±20.87 | 359.37±14.59 | 333.62±16.37 | 332. 37±8.07 |
| Hb (g/dL) | 20.25±0.78 | 16.12±0.53**## | 20.45±1.45## | 20.11±0.92## |
| HT (%) | 38.87±0.6 | 36.14±0.35**## | 39.57±0.99## | 38.2±0.61## |
Values are means ± SEM, n: number of animals in each group.
*p<0.05, **p<0.01, ***p<0.001: significantly different from control group.
#p<0.05, ##p<0.01, ###p<0.001: significantly different from NaNO3.
Biochemical parameters in control and treated rats with NaNO3, PSO or their combination (NaNO3/PSO) during 28 days.
| Parameters and | Control | NaNO3 | PSO | NaNO3/PSO |
| Glucose (g/L) | 0.92±0.03 | 1.3±0.15* | 0.84±0.02## | 0.85±0.03## |
| NO (m M/L) | 1.61±0.06 | 2.13±0.04*** | 1.69±0.07## | 1.8±0.03*### |
| Total bilirubin (mg/L) | 1.48±0.09 | 2.18±0.17** | 1.54±0.13## | 1.71±0.09# |
| Total proteins (g/dL) | 75.75±1.07 | 62.58±2.54** | 79.82±1.77### | 73.96±1.813## |
| AST (U/L) | 173.56±8.55 | 223.45±12.28** | 163.53±7.18## | 189.48±9.04# |
| ALT (U/L) | 55.79±3.49 | 79.5±2.73** | 40.99±1.72***### | 62.53±3.04## |
| ALP (U/L) | 97.57±6.66 | 140.88±9.91** | 99.65±6.03## | 105.61±5.61# |
| LDH (U/L) | 575.23±31.22 | 772.4±31.53** | 457.5±37.48*### | 654.85±31.23# |
Values are means ± SEM, n: number of animals in each group.
*p<0.05, **p<0.01, ***p<0.001: significantlydifferent from control group.
#p<0.05, ##p<0.01, ###p<0.001: significantly different from NaNO3.
MDA, PCO, AOPP and non-enzymatic antioxidant (GSH, vitamin C) levels in liver of control and treated rats with NaNO3, PSO or their combination (NaNO3/PSO) during 28 days.
| Parameters and treatments | Control | NaNO3 | PSO | NaNO3/PSO |
| MDA (nmol/mg prot.) | 2.56±0.23 | 5.25±0.17*** | 1.85±0.11*### | 3.15±0.28### |
| PCO (nmol/mg prot.) | 46.96±3.67 | 69.18±4.92** | 46.38±3.75## | 57.14±1.91*# |
| AOPP (µmol/mg prot.) | 18.83±1.62 | 35.88±2.14*** | 13.1±0.38**### | 21.02±3.65### |
| GSH (nmol/mg prot.) | 2.12±0.03 | 1.71±0.08** | 2.14±0.03## | 2.03±0.05# |
| Vit C (µmol/mg prot.) | 0.1±0.01 | 0.06±0.01** | 0.15±0.02## | 0.1±0.01# |
Values are means ± SEM, n: number of animals in each group.
*p<0.05, **p<0.01, ***p<0.001: significantly different from control group.
#p<0.05, ##p<0.01, ###p<0.001: significantlydifferent from NaNO3.
Antioxidant enzyme activities (GPx, CAT, SOD and GST) in liver of control and treated rats with NaNO3, PSO or their combination (NaNO3/PSO) during 28 days.
| Parameters and treatments | Control (n=10) | NaNO3 (n=10) | PSO (n=10) | NaNO3/PSO (n=10) |
| GPx (µmol GSH/mg prot.) | 0.8±0.04 | 0.52±0.05** | 0.86±0.03## | 0.74±0.04# |
| CAT (µmol H2O2/min/mg prot.) | 286.24±13.14 | 213.34±8.91** | 295.84±2.14### | 245.94±10.14# |
| SOD (U/mg prot.) | 242.08±4.28 | 200.45±3.29*** | 257.8±5.78### | 224.11±5.53## |
| GST (µmol C-DNB/min/mg prot.) | 0.08±0.005 | 0.04±0.006** | 0.08±0.01## | 0.08±0.01# |
Values are means ± SEM, n: number of animals ineach group.
*p<0.05, **p<0.01, ***p<0.001: significantly different from control group.
#p<0.05, ##p<0.01, ###p<0.001: significantly different from NaNO3.
Semiquantitative scoring of architectural damage on histopathological examination of control and treated rats with NaNO3, PSO or their combination (NaNO3/PSO) during 28 days.
| Treatments | Control | NaNO3 | PSO | NaNO3/PSO |
| Sinusoidal dilatation | (-) | (+++) | (-) | (++) |
| Inflammatory cells infiltration | (-) | (+++) | (-) | (+) |
| Degeneration of hepatocytes | (-) | (++) | (-) | (-) |
| Vien congestion | (-) | (+++) | (-) | (++) |
(-) indicates normal, (+) indicates mild, (++) indicates moderate and (+++) indicates severe.
Figure 1Histological liver sections of controls, with normal architecture, (B) NaNO3 treated group, (C) PSO treated group and (D) NaNO3/PSO treated group during 28 days. Optic microscopy: H&E (X400). Hepatocytes degeneration (black arrow), vein congestion (white arrow), inflammatory cell infiltration (circle), sinusoidal dilatation (Star).